NCT05120518 Post Mortem Tissue Donation of Pediatric Tumor Tissues and Cells
| NCT ID | NCT05120518 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ann & Robert H Lurie Children's Hospital of Chicago |
| Condition | Pediatric Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 150 participants |
| Start Date | 2019-08-14 |
| Primary Completion | 2029-08-14 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 150 participants in total. It began in 2019-08-14 with a primary completion date of 2029-08-14.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this study is to utilize all donated pediatric tumor tissues and cells obtained from autopsy to prospectively develop novel patient derived orthotopic xenograft (PDOX) mouse models as well as in vitro cell culture model systems for pediatric cancers, and also provide tissue samples to other researchers and organizations (eg, CBTN, DIPG Registry, COG).
Eligibility Criteria
Inclusion Criteria: * Pediatric patients with cancer and non-cancer tumor types (solid, liquid, neuro-oncology) * Signed consent for post mortem tissue donation and autopsy Exclusion Criteria: * Signed consent for post mortem tissue donation and autopsy not obtained
Contact & Investigator
Angela Waanders, MD
PRINCIPAL INVESTIGATOR
Ann & Robert H Lurie Children's Hospital of Chicago
Frequently Asked Questions
Who can join the NCT05120518 clinical trial?
This trial is open to participants of all sexes, studying Pediatric Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05120518 currently recruiting?
Yes, NCT05120518 is actively recruiting participants. Contact the research team at awaanders@luriechildrens.org for enrollment information.
Where is the NCT05120518 trial being conducted?
This trial is being conducted at Chicago, United States.
Who is sponsoring the NCT05120518 clinical trial?
NCT05120518 is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago. The principal investigator is Angela Waanders, MD at Ann & Robert H Lurie Children's Hospital of Chicago. The trial plans to enroll 150 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.